CHESHIRE, Conn., Jan. 5 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the 27th Annual JP Morgan Healthcare Conference in San Francisco at 4:30 p.m.

Alexion Licenses PDL's Queen et al. Patents for Soliris(R) INCLINE VILLAGE, Nev., and CHESHIRE, Conn., Jan. 5 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) and Alexion Pharmaceuticals, Inc.

CHESHIRE, Conn., June 18 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Jefferies & Co.

By Benjamin N. Gedan; Journal Staff Writer Alexion Pharmaceuticals is rapidly expanding its sales force and launching programs aimed at increasing the diagnosis of a rare blood disease treated with Soliris, a drug the company makes, its chief executive officer said yesterday.

CHESHIRE, Conn., June 13 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc.